Francesco Schittulli

2.6k total citations
75 papers, 1.9k citations indexed

About

Francesco Schittulli is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Francesco Schittulli has authored 75 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 28 papers in Cancer Research and 25 papers in Genetics. Recurrent topics in Francesco Schittulli's work include Breast Cancer Treatment Studies (22 papers), HER2/EGFR in Cancer Research (16 papers) and BRCA gene mutations in cancer (14 papers). Francesco Schittulli is often cited by papers focused on Breast Cancer Treatment Studies (22 papers), HER2/EGFR in Cancer Research (16 papers) and BRCA gene mutations in cancer (14 papers). Francesco Schittulli collaborates with scholars based in Italy, United States and Malaysia. Francesco Schittulli's co-authors include Angelo Paradiso, Stefania Tommasi, Anita Mangia, Annalisa Chiriatti, Michele Quaranta, Agnese Latorre, Vito Lorusso, Nadia Harbeck, Manfred Schmitt and John A. Foekens and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Francesco Schittulli

75 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesco Schittulli Italy 24 976 817 728 393 167 75 1.9k
Iris L. van Staveren Netherlands 22 1.1k 1.1× 968 1.2× 689 0.9× 467 1.2× 192 1.1× 25 1.9k
Elisabeth Mueller‐Holzner Austria 18 1.5k 1.5× 679 0.8× 523 0.7× 199 0.5× 187 1.1× 31 2.1k
A.L. Børresen-Dale Norway 20 1.5k 1.5× 970 1.2× 762 1.0× 339 0.9× 352 2.1× 41 2.4k
Tuula Kuukasjärvi Finland 20 892 0.9× 834 1.0× 633 0.9× 602 1.5× 245 1.5× 25 1.8k
F. Spyratos France 23 906 0.9× 1.0k 1.2× 796 1.1× 389 1.0× 290 1.7× 52 2.0k
Teijo Kuopio Finland 25 791 0.8× 886 1.1× 636 0.9× 274 0.7× 409 2.4× 119 2.2k
Todd G. Kroll United States 19 1.5k 1.5× 715 0.9× 573 0.8× 499 1.3× 275 1.6× 23 2.8k
Heather Thorne Australia 18 1.2k 1.2× 1.1k 1.3× 761 1.0× 568 1.4× 222 1.3× 40 2.2k
Ingrid Hedenfalk Sweden 28 1.1k 1.1× 824 1.0× 852 1.2× 546 1.4× 181 1.1× 78 2.4k
Sten Wingren Sweden 24 701 0.7× 1.0k 1.3× 625 0.9× 581 1.5× 443 2.7× 63 2.1k

Countries citing papers authored by Francesco Schittulli

Since Specialization
Citations

This map shows the geographic impact of Francesco Schittulli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Schittulli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Schittulli more than expected).

Fields of papers citing papers by Francesco Schittulli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Schittulli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Schittulli. The network helps show where Francesco Schittulli may publish in the future.

Co-authorship network of co-authors of Francesco Schittulli

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Schittulli. A scholar is included among the top collaborators of Francesco Schittulli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Schittulli. Francesco Schittulli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piscitelli, Prisco, et al.. (2025). Recognizing the limits of the 21 different Italian healthcare regional systems: an opportunity for change?. The Lancet Regional Health - Europe. 51. 101250–101250. 1 indexed citations
2.
Torino, Francesco, Agnese Barnabei, Liana De Vecchis, et al.. (2013). Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. Critical Reviews in Oncology/Hematology. 89(1). 27–42. 54 indexed citations
3.
4.
Seymour, Ian, Silvia Casadei, Valentina Zampiga, et al.. (2008). Disease family history and modification of breast cancer risk in common BRCA2 variants. Oncology Reports. 19(3). 783–6. 12 indexed citations
5.
Yau, Christina, Vita Fedele, Ritu Roydasgupta, et al.. (2007). Aging Impacts Transcriptome but not Genome of Hormone-dependent Breast Cancers. eScholarship (California Digital Library). 1 indexed citations
6.
7.
Chiriatti, Annalisa, Anita Mangia, Stefania Tommasi, et al.. (2007). P47 BRCA1, ER-alpha expression and molecular BRCA1 alterations in familial and sporadic breast cancer. European Journal of Cancer Supplements. 5(8). 21–21. 1 indexed citations
8.
Tommasi, Stefania, Anita Mangia, Rosanna Lacalamita, et al.. (2007). Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β‐tubulins. International Journal of Cancer. 120(10). 2078–2085. 130 indexed citations
9.
Quaranta, Michele, Antonella Daniele, M. Coviello, et al.. (2006). C-Erbb-2 Protein Level in Tissue and Sera of Breast Cancer Patients: A Possibly Useful Clinical Correlation. Tumori Journal. 92(4). 311–317. 18 indexed citations
10.
Tommasi, Stefania, Rosanna Lacalamita, Alessandro Monaco, et al.. (2005). BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 578(1-2). 395–405. 49 indexed citations
11.
Cipollini, Giovanna, Stefania Tommasi, Angelo Paradiso, et al.. (2004). Genetic alterations in hereditary breast cancer. Annals of Oncology. 15. i7–i13. 42 indexed citations
12.
Volpi, Annalisa, Oriana Nanni, Franca De Paola, et al.. (2003). HER-2 Expression and Cell Proliferation: Prognostic Markers in Patients With Node-Negative Breast Cancer. Journal of Clinical Oncology. 21(14). 2708–2712. 37 indexed citations
13.
Lorusso, Vito, E. Crucitta, Nicola Silvestris, et al.. (2003). Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer. British Journal of Cancer. 88(4). 491–495. 9 indexed citations
14.
Mangia, Anita, Stefania Tommasi, Stephan J. Reshkin, et al.. (2002). Gonadotropin releasing hormone receptor expression in primary breast cancer: Comparison of immunohistochemical, radioligand and Western blot analyses. Oncology Reports. 9(5). 1127–32. 27 indexed citations
15.
Paradiso, Angelo, Girolamo Ranieri, Nicola Silvestris, et al.. (2001). Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis. Clinical and Experimental Medicine. 1(3). 127–132. 5 indexed citations
16.
17.
Paradiso, Angelo, et al.. (1993). Mammography and Morphobiologic Characteristics of Human Breast Cancer. Tumori Journal. 79(6). 422–426. 3 indexed citations
18.
Ciatto, Stefano, Luigi Cataliotti, Gaetano Cardona, et al.. (1992). Risk of Infiltrating Breast Cancer Subsequent to Lobular Carcinoma in Situ. Tumori Journal. 78(4). 244–246. 10 indexed citations
19.
Quaranta, Michele, et al.. (1991). [Clinical usefulness of CA M26 and CA M29 in breast carcinoma].. PubMed. 34(4 Suppl). 35–8. 1 indexed citations
20.
Paradiso, Angelo, Vito Lorusso, Stefania Tommasi, et al.. (1988). Relevance of cell kinetics to hormonal response of receptor-positive advanced breast cancer. Breast Cancer Research and Treatment. 11(1). 31–36. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iris L. van Staveren Breakdown of academic impact, for papers by Elisabeth Mueller‐Holzner Breakdown of academic impact, for papers by A.L. Børresen-Dale Breakdown of academic impact, for papers by Tuula Kuukasjärvi Breakdown of academic impact, for papers by F. Spyratos Breakdown of academic impact, for papers by Teijo Kuopio Breakdown of academic impact, for papers by Todd G. Kroll Breakdown of academic impact, for papers by Heather Thorne Breakdown of academic impact, for papers by Ingrid Hedenfalk Breakdown of academic impact, for papers by Sten Wingren
Rankless by CCL
2026